Top Markets
#1 Nesa Nesa +798.54%
#2 Cortex Cortex +68.78%
#3 Kinesis Silver Kinesis Silver +55.88%
#4 Merlin's Seal BTC Merlin's Seal BTC +45.67%
#5 QuantixAI QuantixAI +24.00%
#6 EXOD EXOD +22.78%
#7 Cash Cat Cash Cat +22.65%
#8 OpenEden OpenEden +17.60%
#9 Instadapp Instadapp +16.15%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +15.81%
Coin of the day
Nesa Nesa
設定
言語
日本
通貨
USD
テーマ
Caliway Biopharmaceuticals Co. L Caliway Biopharmaceuticals Co. L

Caliway Biopharmaceuticals Co. L

6919
株式のランク #3557
Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated... Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated to developing pharmaceuticals primarily in the fields of aesthetic medicine and chronic inflammation. Its lead investigational drug, CBL-514, is currently undergoing Phase 2 clinical trials, targeting non-surgical fat reduction, Dercum's disease, and cellulite. Beyond this, the firm is also progressing CBA-539 through preclinical exploration for potential applications in central obesity, hyperpigmentation, and skin aging. The company's offerings also extend to dietary supplements. Established in 2012, Caliway Biopharmaceuticals operates from its headquarters in New Taipei City, Taiwan.
株価
$3.28
最終同期: 2026-07-31
時価総額
$5.10B
変化（1日）
0.00%
変化（1年）
-49.70%
国
TW
取引 Caliway Biopharmaceuticals Co. L (6919)

カテゴリー

Healthcare
Caliway Biopharmaceuticals Co. L（6919）の配当利回りの履歴
Caliway Biopharmaceuticals Co. L（銘柄コード: 6919）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Caliway Biopharmaceuticals Co. L（6919）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH